![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 북미 분자생물학 효소, 키트 및 시약 시장 예측 – 제품별(효소 및 키트 및 시약), 애플리케이션별(후생유전학, 시퀀싱, 합성 생물학, 중합효소 연쇄 반응 등)별 코로나19 영향 및 지역 분석 최종 사용자(생명공학 및 제약 회사, 병원 및 진단 센터, 학술 및 연구 기관)
시장 소개
북미는 분자생물학 효소, 키트 및 제품 분야에서 가장 큰 시장입니다. 시약은 미국이 가장 큰 시장 점유율을 차지하고 캐나다가 그 뒤를 따릅니다. 북미 지역의 성장은 암 발병률 증가, 주요 시장 참여자 확립, 다양한 학계 및 연구 기관에서 수행하는 광범위한 R&D를 특징으로 합니다. 또한, COVID-19의 발생률 증가는 예측 기간 동안 시장 성장을 지원합니다. 암 치료제 개발, 노인 인구 증가, 전염병 및 기타 치료법 개발을 위해 제조 회사는 물론 학계 및 연구 기관에 투자하는 투자가 늘어나고 자금도 늘어나는 것이 주요 원동력 중 하나입니다.
코로나19 팬데믹은 분자생물학 효소, 키트 및 산업 분야에서 활동하는 플레이어에게 유리한 시나리오를 보여주었습니다. 시약 시장. 미국은 북미에서 큰 영향을 받은 국가였습니다. 코로나19의 영향은 노인들에게 부정적입니다. 노인들 사이의 코로나19 감염으로 인해 심각한 합병증이 발생했으며 국내에서 많은 사망자가 발생했습니다. 팬데믹 기간 동안 생명과학 회사들은 생명을 위협하는 질병을 치료하기 위한 신약 개발에 참여했습니다. 따라서 분자 생물학 효소, 키트 & 시약 제품은 의약품 설계 및 제조에 필요합니다. 개발 및 코로나19 진단.
게다가 코로나19 사례 증가는 분자생물학 효소, 키트 및 진단에 긍정적인 영향을 미쳤습니다. 시약 시장. 2021년 3월, Eurofins\' Clinical Enterprise, Inc.는 EmpowerDX 코로나19 홈 컬렉션 키트의 소비자 직접 판매(DTC) 버전에 대해 미국 식품의약국(FDA)으로부터 긴급 사용 승인(EUA)을 획득했습니다. Eurofins의 가정용 코로나19 비강 PCR 키트는 유럽 연합이 승인한 최초의 일반의약품 SARS-CoV-2 가정용 테스트 키트 중 하나입니다. 따라서 제품 출시의 증가는 시장 성장을 뒷받침합니다. 마찬가지로 2020년 7월 Eurofins US Clinical Diagnostics는 SARS-CoV-2를 탐지하기 위한 통합 PCR 테스트를 사용할 수 있다고 발표했습니다. 이는 고객의 PCR 테스트당 비용을 크게 낮출 것입니다.
< u>시장 개요 및 역학
북미의 분자 생물학 효소, 키트 및 시약 시장은 미화 55억 3,213만 달러에서 성장할 것으로 예상됩니다. 2021년에는 2028년까지 179억 9975만 달러로 증가할 것입니다. 2021년부터 2028년까지 CAGR 18.4%로 증가할 것으로 추정됩니다. WHO 제안에 따르면 암으로 인한 사망의 30~50%는 초기 단계의 적절한 치료를 통해 예방할 수 있습니다. 이 시나리오에서 맞춤형 의학은 기존 치료법에 효과적으로 반응하는 것으로 잘 알려지지 않은 질병을 해결하는 가장 유망한 접근 방식을 제공합니다. PMC에 발표된 연구에 따르면, 맞춤형 의약품은 2005년에 FDA가 승인한 새로운 분자 개체 중 5%만을 차지한 반면, 2016년에는 25% 이상을 차지했습니다. 또한 전체 화합물의 42%, 73개 파이프라인에 있는 종양학 화합물의 %는 맞춤형 의약품이 될 가능성이 있습니다. 더욱이 바이오제약 기업은 지난 5년 동안 맞춤형 의약품에 대한 R&D 투자를 거의 두 배로 늘렸으며, 향후 5년간 33% 증가할 것으로 예상됩니다. 생물약제학 연구자들은 또한 향후 5년 동안 개발 중인 맞춤형 의약품의 수가 69% 증가할 것으로 예측합니다.
주요 시장 부문
북미 분자 생물학 효소, 키트 및 시약 시장은 다음과 같이 분류됩니다. , 애플리케이션, 최종 사용자 및 국가. 제품을 기준으로 분자 생물학 효소, 키트 및 시약 시장은 효소와 키트 & 시약. 시장은 효소에 따라 중합효소, 리가아제, 역전사효소, 포스파타아제, 프로테아제 및 단백질분해효소, 제한 엔도뉴클레아제 등으로 더욱 세분화됩니다. 키트 & 시약 부문은 2020년에 더 큰 시장 점유율을 차지했습니다. 분자 생물학 효소, 키트 및 시약 시장은 응용 분야에 따라 후생유전학, 시퀀싱, 합성 생물학, 중합효소 연쇄 반응 등으로 분류됩니다. 2020년에는 시퀀싱 부문이 가장 큰 시장 점유율을 차지했습니다. 최종 사용자 측면에서 분자 생물학 효소, 키트 및 시약 시장은 생명공학 및 제약 회사, 병원 및 진단 센터, 학술 및 연구 기관으로 분류됩니다. 생명 공학 및 제약 회사 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다. 국가를 기준으로 북미 분자 생물학 효소, 키트 및 시약 시장은 미국, 캐나다 및 멕시코로 분류됩니다. 미국은 2020년에 가장 큰 시장 점유율을 차지했습니다.
주요 출처 및 상장 회사
몇 가지 주요 1차 및 2차 출처를 참조했습니다. 북미 분자생물학 효소, 키트 및 시약 시장에 대한 이 보고서를 준비하는 데에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서 및 통계 데이터베이스 등이 포함됩니다. 보고서에 나열된 주요 회사는 Agilent Technologies, Inc.입니다. F. HOFFMANN-LA ROCHE LTD; 일루미나, Inc.; 머크 KGAA; 메리디안 바이오사이언스, INC; 프로메가 코퍼레이션; 퀴아겐; Rockland Immunochemicals Inc; 및 THERMO FISHER SCIENTIFIC INC.
구매 이유 보고서
- 북미 분자 생물학 효소, 키트 및 시약 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다.
- 북미 분자생물학 효소, 키트 및 시약 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- 북미 지역에서 M&A 및 파트너십 거래를 효율적으로 계획하세요. 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 미국 분자 생물학 효소, 키트 및 시약 시장.
- 북미 분자 생물학을 비롯한 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. 효소, 키트 및 시약 시장.
- 2021~2028년 북미 지역의 다양한 부문별 시장 수익 예측을 알아보세요.
북미 분자 생물학 효소, 키트 및 시약 시장 세분화
북미 분자 생물학 효소, 키트 및 시약 시장 - 제품별
- 효소
- 중합효소
- 리가제
- 역전사효소
- 인산분해효소
- 프로테아제 및 단백질분해효소
- 제한 엔도뉴클레아제
- 기타
- 키트 및 시약
북미 분자 생물학 효소, 키트 및 시약 시장 - 기준 응용
- 후생유전학
- 서열 분석
- 합성 생물학
- 중합효소 연쇄 반응
- 기타
북미 분자 생물학 효소, 키트 및 시약 시장 - 최종 사용자별
- 생명공학 및 제약 회사
- 병원 및 진단 센터
- 학술 및 연구 기관
북미 분자 생물학 효소, 키트 및 시약 시장 - 국가별
- 미국
- 캐나다 li>
- 멕시코
북미 분자 생물학 효소, 키트 및 시약 시장 - 회사 프로필
- Agilent Technologies , Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 North America Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 North America Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 North America Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 North America PEST Analysis
4.1.1 Expert Opinion
5. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Highly Funded
5.1.2 Sequencing Procedures becoming Cheaper
5.1.3 Rising Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Scarcity of Skilled Professionals
5.3 Market Opportunities
5.3.1 Molecular Diagnostics Getting Highly Adopted
5.4 Future Trends
5.4.1 Personalized Medicines at High Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – North America Analysis
6.1 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 North America
10.1.1 Overview
10.1.2 North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.2.1 US
10.1.2.1.1 US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.1.4 US: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada
10.1.2.2.1 Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico
10.1.2.3.1 Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Molecular Biology Enzymes, Kits & Reagents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Rockland Immunochemicals, Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Promega Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. US: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. US: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 14. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. North America Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of North America Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. North America Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. North America Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. North America Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. North America Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in North American Country Markets
Figure 35. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America molecular biology enzymes, kits, and reagents market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America molecular biology enzymes, kits, and reagents market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the molecular biology enzymes, kits, and reagents market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution